TREATING CANCER BY INHIBITING EXPRESSION OF OLFM4, SP5, TOBI, ARJDIA, FBNI OR HAT1

• 收藏
• 分享

专利权人:

NATIONAL UNIVERSITY OF SINGAPORE

发明人:

TAN, PATRICK,OH, HUE KIAN

申请号：

SG2013060785

公开号：

SG192707A1

申请日:

2012.02.13

申请国别(地区):

SG

年份:

2013

代理人:

摘要：

The present invention in one aspect relates to a method for treating cancer or enhancing a cancer treatment, the method comprising inhibiting the expression of an oligonucleotide encoding for a protein selected from the group consisting of OLFM4, SP5, TOB1, ARID1A, FBN1 and HAT1, by administering to a mammal in need of cancer treatment an effective amount of at least one silencing oligonucleotide comprising a binding motif for binding to the oligonucleotide encoding for a protein.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/